BeyondSpring announced that on October 27, 2023, it received a written notification from the Listing Qualifications Department from The Nasdaq Stock Market that the Company has regained compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the Nasdaq Listing Rules. According to the Notification Letter on Compliance, the staff of Nasdaq has determined that for the 10 consecutive business days, from October 13, 2023 to October 26, 2023, the closing bid price of the Company’s ordinary shares has been at $1.00 per share or greater, and the Company has regained compliance with the Nasdaq Listing Rule 5550(a)(2) and the bid price deficiency matter as previously disclosed is now closed.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BYSI:
- BeyondSpring’s Seed Therapeutics discloses IND candidate, ST-00937
- SEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at “Targeted Protein Degradation Think Tank” Symposium
- SEED Therapeutics, a BeyondSpring Subsidiary, Appoints Mr. Ko-Yung Tung to the Board of Directors
- BeyondSpring receives noncompliance notification from Nasdaq
- BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements